-
AVXL Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Anavex Life Sciences (AVXL)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 144 |
Opened positions | 29 |
Closed positions | 25 |
Increased positions | 37 |
Reduced positions | 40 |
13F shares | Current |
---|---|
Total value | 109.76 bn |
Total shares | 26.77 mm |
Total puts | 760.50 k |
Total calls | 673.70 k |
Total put/call ratio | 1.1 |
Largest owners | Shares | Value |
---|---|---|
BLK BlackRock | 6.39 mm | $26.97 bn |
Vanguard | 4.55 mm | $19.19 bn |
STT State Street | 3.74 mm | $15.78 bn |
Geode Capital Management | 1.83 mm | $7.73 bn |
Two Sigma Investments | 1.01 mm | $4.27 bn |
NTRS Northern Trust | 669.16 k | $2.82 bn |
Charles Schwab Investment Management | 651.08 k | $2.75 bn |
Two Sigma Advisers | 633.00 k | $2.67 bn |
BAC Bank of America | 600.36 k | $2.53 bn |
Renaissance Technologies | 466.44 k | $1.97 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Dec 24 | Sandra Boenisch | Stock Option Common Stock | Grant | Acquire A | No | No | 5.36 | 12,500 | 67.00 k | 12,500 |
19 Dec 24 | Christopher U Missling | Stock Option Common Stock | Grant | Acquire A | No | No | 5.36 | 125,000 | 670.00 k | 125,000 |
19 Nov 24 | Christopher U Missling | Stock Option Common Stock | Grant | Acquire A | No | No | 10.09 | 125,000 | 1.26 mm | 250,000 |
19 Nov 24 | Sandra Boenisch | Stock Option Common Stock | Grant | Acquire A | No | No | 10.09 | 10,000 | 100.90 k | 20,000 |
14 Jun 24 | Peter D.O. Donhauser | Common Stock | Buy | Acquire P | No | No | 3.64 | 2,835 | 10.32 k | 5,000 |